- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jacque Sokolov Discusses Health Care Transformation Ahead of NAMCP Spring Managed Care Forum 2023
Jacque Sokolov, MD, president and chairman at SSB Solutions, previews his keynote presentation and discusses the unique, shifting health care atmosphere leading into the National Association of Managed Care Physicians (NAMCP) Spring Managed Care Forum 2023.
Jacque Sokolov, MD, president and chairman at SSB Solutions, previews his keynote presentation and discusses the unique, shifting health care atmosphere leading into the National Association of Managed Care Physicians (NAMCP) Spring Managed Care Forum 2023, which runs from April 26-28 in Orlando, FL.
Transcript
What are you most looking forward to at this year’s meeting?
This spring forum in 2023 is arguably one of the most unique forums I think I've ever had the opportunity to keynote. The year is post pandemic, and now we're endemic in terms of COVID-19. The clinical, business, and operational models that are transforming health care have been amplified, and we're all starting to understand how they are affecting everyday life in terms of the health care sectors we deal with.
What are the main drivers of health care market transformation that you’ll be discussing in your keynote presentation?
There'll be 3 areas of transformation that will be focused on. From the clinical transformation area, there could be many, but I'm picking biopharma and AI [artificial intelligence] as the 2 areas that I think are most impactful. From a business transformation perspective, I think it is the super aggregators and the consolidation of certain sectors of the health care economy. And from an operating perspective, I think, quite candidly, it is the appreciation of the workforce burnout and disparity issues that we've seen as a result of COVID-19 and the stress on the US health care system.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS
June 24th 2025In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.
Read More
